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A new method for the immobilization of α1-acid glycoprotein (AGP) in HPLC columns was recently
described for applications such as drug binding studies. Part of this earlier work used self-competition
zonal elution studies to measure association equilibrium constants between immobilized AGP and
R- or S-propranolol. It was later found that analysis of these data by a common equation derived for
linear elution conditions gave erroneous values for experiments actually conducted under nonlinear
conditions. This report discusses the nature of this error and uses frontal analysis to estimate the true
binding strength between R- and S-propranolol and HPLC columns containing immobilized AGP.
A recent paper examined the binding of R- and S-propranolol to a new type of α1-acid
glycoprotein (AGP) column (1). Part of this earlier work used self-competition zonal elution
studies for association equilibrium constant measurements, an approach which has since been
noted to contain some errors that are not uncommon in the literature but that do need to be
corrected to better estimate the true binding strength of R- and S-propranolol with AGP.
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The column used in Ref. (1) was prepared through the controlled and mild oxidation of AGP,
followed by the immobilization of this protein to hydrazide-activated silica. Part of this paper
evaluated binding of this AGP column to R- and S-propranolol by using a self-competition
zonal elution experiment (i.e., the “perturbation method”, “step and pulse method” or “system
peak” method) (2–4). In this approach, a small sample of R- or S-propranolol was injected as
a pulse onto the AGP column while a known, fixed concentration of the same compound was
applied in the mobile phase as a competing agent. The resulting shift in the retention factor
(k’) for the observed peak was measured as a function of the mobile phase concentration of the
analyte [A]. Plots of 1/k’ versus [A] appeared to give a linear response for mobile phases
containing 0 to 5 µM propranolol.
In these experiments (1), association equilibrium constants were obtained by fitting the data
to an equation from the literature that pertains to an analyte at infinite dilution, or "linear elution
conditions" (see Eq. 1 in Ref. 1 and equivalent equations in Refs. 5 and 6). However, for an
analyte at a finite concentration, this same equation can introduce errors when obtaining
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association equilibrium constants. The error arises because Eq. 1 in Ref. 1 is strictly valid only
for the bolus of molecules that are injected into the column but not for the peak that is actually
observed in the chromatogram. This latter peak is called the “perturbation peak” or
“displacement peak” and is caused by perturbation of the liquid/solid equilibrium in the column
due to sample injection. Although the injection of sample causes this perturbation, the sample
and this perturbation do not elute at the same time from the column. This phenomenon is
predicted under nonlinear elution conditions by chromatographic theory and has been observed
in recent experiments (7–10). Molecules contained in the injected pulse exit as a “mass” peak
which cannot be observed directly unless these molecules are distinguishable from the
competing agent by an appropriate detector (e.g., using an isotopically-labeled analyte and a
radioactivity detector or mass spectrometer; see chromatograms in Ref. 8 for examples). Failure
to consider the difference in the mass and perturbation peaks leads to a systematic error in the
measurement of an equilibrium constant by zonal elution when nonlinear elution conditions
are present unless more complex expressions than Eq. 1 in Ref. (1) are used for data analysis
(see Supplementary materials). The size of this error will depend on the concentration of the
competing agent and the equilibrium constant for the system (7–9).
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In this current report, improved estimates of the association equilibrium constants for R- and
S-propranolol on the AGP column were obtained by using frontal analysis, or “breakthrough
curve” analysis (3,10–12). Frontal analysis is a well-established technique that can be
performed under nonlinear conditions by determining the amount of analyte required to reach
the mean saturation point of a column at various applied concentrations of the analyte. Both
zonal elution and frontal analysis have been shown to give comparable binding parameters
when their data are fit to the appropriate equations [13]. However, frontal analysis gives raw
adsorption isotherm data while zonal elution gives the best estimates of the isotherm parameters
[9]. As a result, frontal analysis is not subject to errors due to differences in mass peaks versus
perturbation peaks.
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Frontal analysis was performed by utilizing the same type of AGP support as employed for the
zonal elution studies (see Ref. (1) for details on the preparation of this material). These
experiments were conducted using 50 × 4.1 mm I.D. stainless steel columns that contained
immobilized AGP or a control support prepared under identical conditions but with no AGP
being added during the immobilization step. All columns were enclosed in water jackets and
attached to a circulating water bath for temperature control (1). Breakthrough curves were
generated on these columns at 1.00 mL/min using solutions that contained 0.10 µM to 1.50
mM R- or S-propranolol in pH 7.4, 0.067 M phosphate buffer. After sample application, the
retained analyte was eluted by passing pH 7.4, 0.067 M phosphate buffer alone through the
column. All results were corrected for the column void time and any nonspecific binding of
propranolol to the control column (note: this latter value made up less than 22% of the total
binding capacity measured on the AGP column).
Figure 1 shows a plot of mLapp versus [R-Propranolol] for frontal analysis data obtained at
37.0°C, where mLapp represents the moles of applied analyte required at a given analyte
concentration to reach the mean point of the breakthrough curve. This plot has a sharp increase
in mLapp versus [R-Propranolol] at low-to-moderate concentrations (i.e., 0.1–100 µM),
followed by a more gradual increase in mLapp at higher propranolol concentrations. Similar
results were obtained for S-propranolol. This behavior has been noted previously with
immobilized or soluble AGP at 37.0°C over a comparable concentration range of beta-blockers
(12,14) and has been attributed to the presence of two populations of binding sites: 1) a selective
high affinity site present in approximately a stoichiometric amount versus AGP, and 2) a group
of lower affinity, non-selective sites. When the results in Figure 1 were fit to such a “two-site”
model, this gave a best-fit response with a correlation coefficient of 0.9964 (n = 15) for Rpropranolol and 0.9901 (n = 17) for S-propranolol.
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As shown in Table 1, the selective site/non-selective two-site model gave an association
equilibrium constant for the selective site (Ka1) equal to 1.1 × 106 M−1 for R-propranolol and
1.4 × 106 M−1 for S-propranolol at 37.0°C. The stoichiometric ratio for this selective site (n1)
was 0.53–0.57 when compared to a total content of 73 (± 2) nmol AGP in the column. This
result is similar to a previous one obtained for alprenolol on AGP (12). The second group of
non-selective sites gave a best-fit value for the product n2Ka2 that was 2,160 (± 70) M−1 or
1,340 (± 70) M−1 for R- and S-propranolol. The resulting fit was practically equivalent to that
obtained for a bi-Langmuir model in which the denominator in the term (mL2 Ka2
[Propranolol])/(1 + Ka2 [Propranolol]) is approximately equal to one, where mL2 represents
the total moles of "non-selective" sites in the column. This behavior occurs when the product
Ka2 [Propranolol]) is small compared to one and may explain why non-saturable behavior has
been observed for the second class of sites on AGP. The values of Ka1 obtained with the biLangmuir model were statistically equivalent to those in Table 1 for the selective site/nonselective site model.
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The best-fit results for the selective site/non-selective site model indicate that there are two
types of binding sites for R- and S-propranolol on AGP. These results also suggest that, at
propranolol concentrations below 50 µM, most of the binding by AGP involves the high affinity
selective sites. It is estimated that binding to the selective sites accounts for a large fraction of
the binding by AGP when propranolol concentrations approach infinite dilution (i.e., below 1
µM), with this contribution decreasing to approximately 80% of the total binding measured
for 50 µM propranolol (on a column with an effective AGP concentration of 140 µM). This
observation explains why many former binding studies using similar concentrations of AGP
and propranolol have not observed the non-selective sites. These results also suggest that the
non-selective sites play a negligible role in the binding of AGP at the typical therapeutic levels
of propranolol (0.2–0.4 µM versus 13–34 µM AGP) (14); however, such nonselective binding
must be considered on a case-by-case basis and may play a more important role in the binding
of other compounds to AGP.
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Table 1 compares the frontal analysis results for Ka1 with the apparent values measured in Ref.
(1) by self-competition zonal elution experiments. The frontal analysis results at 37.0°C were
2.5 to 3-fold lower than those reported in Ref. (1); a similar comparison made at 15°C gave 4
to 5-fold lower values (data not shown). The lower values measured by frontal analysis can be
explained by the expected differences in the retention factors of the displacement and the mass
peaks in the self-competition zonal elution studies. Another important difference in the results
shown in Table 1 is that the zonal elution values were interpreted using a one-site interaction
model while the frontal analysis values were acquired over a broader range of propranolol
concentrations and were analyzed with a two-site model, making it possible to consider and
correct for binding at the non-selective sites for propranolol on AGP.
The Ka1 values determined by frontal analysis were closer than the zonal elution results to
solution-phase values reported for the propranolol/AGP system (see literature cited in Table 1
of Ref. (1). This includes better agreement with association equilibrium constants of 0.38–0.63
× 106 M−1 measured at 37.0°C for propranolol enantiomers or 0.4–0.54 × 106 M−1 for racemic
propranolol, and values of 0.84–1.13 × 106 M−1 reported at room temperature for racemic
propranolol. These results support the conclusion reached in Ref. (1) that the new AGP columns
can be used as a model for soluble AGP in drug-protein binding studies. This study also
demonstrates the need for caution in the use of self-competition zonal elution studies for
evaluating the binding properties of immobilized proteins in chromatographic columns.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Frontal analysis results for R-propranolol at pH 7.4 and 37.0°C on a hydrazide-linked AGP
column. The measured values for mLapp had precisions of ±0.4 to 13% over the range of
propranolol concentrations that were examined. The best-fit line shown in this graph is for the
equation mLapp = (mL1Ka1 [Propranolol])/(1 + Ka1[Propranolol]) + (mL2Ka2) [Propranolol],
where Ka1 and Ka2 are the association equilibrium constants for a set of selective and nonselective sites for propranolol on AGP, with mL1 and mL2 being the moles of these binding
sites that are present in the AGP column. Using the total estimated amount of AGP in the
column (mL,AGP), the following relationships were used with the best-fit results to obtain the
values for n1 and n2 Ka2 that are given in the text: mL1/mL,AGP = n1 and (mL2 Ka2)/mL,AGP =
n2 Ka2. The dashed line in the inset shows the response predicted for the high affinity selective
site in the two-site model.
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Table 1

Association equilibrium constants measured at 37.0°C for binding by R- and S-propranolol to the high affinity
selective site on AGP

NIH-PA Author Manuscript

Enantiomer

Zonal elution result

R-Propranolol
S-Propranolol

2.7 (± 0.2) × 106
4.2 (± 0.3) × 106

Association equilibrium constant, Ka1 (M−1)
Frontal analysis resultb
1.1 (± 0.6) × 106
1.4 (± 0.7) × 106

a

These results were determined in pH 7.4, 0.067 M phosphate buffer. The numbers in parentheses represent a range of ±1 S.D.

b

These values are for the selective/non-selective site model. The values obtained for Ka1 when using a bi-Langmuir model were 1.1 (± 0.6) × 106 M−1

and 2.0 (± 0.8) × 106 M−1 for R- and S-propranolol, respectively (see discussion in the text).
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